Your browser doesn't support javascript.
loading
Nimotuzumab combined with concurrent chemoradiotherapy in Japanese patients with esophageal cancer: A phase I study.
Kato, Ken; Ura, Takashi; Koizumi, Wasaburo; Iwasa, Satoru; Katada, Chikatoshi; Azuma, Mizutomo; Ishikura, Satoshi; Nakao, Yoshinori; Onuma, Hiroshi; Muro, Kei.
Affiliation
  • Kato K; Gastrointestinal Medical Oncology Division, National Cancer Center Hospital, Tokyo, Japan.
  • Ura T; Department of Clinical Oncology, Aichi Cancer Center Hospital, Nagoya, Japan.
  • Koizumi W; Department of Gastroenterology, Kitasato University School of Medicine, Kanagawa, Japan.
  • Iwasa S; Gastrointestinal Medical Oncology Division, National Cancer Center Hospital, Tokyo, Japan.
  • Katada C; Department of Gastroenterology, Kitasato University School of Medicine, Kanagawa, Japan.
  • Azuma M; Department of Gastroenterology, Kitasato University School of Medicine, Kanagawa, Japan.
  • Ishikura S; Department of Radiology, Nagoya City University Graduate School of Medical Sciences, Nagoya, Japan.
  • Nakao Y; Pharmacovigilance Department, Daiichi Sankyo Co., Ltd., Tokyo, Japan.
  • Onuma H; Oncology Clinical Development Department, Daiichi Sankyo Co., Ltd., Tokyo, Japan.
  • Muro K; Department of Clinical Oncology, Aichi Cancer Center Hospital, Nagoya, Japan.
Cancer Sci ; 109(3): 785-793, 2018 Mar.
Article in En | MEDLINE | ID: mdl-29285832
Subject(s)
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Esophageal Neoplasms / Antineoplastic Combined Chemotherapy Protocols / Antibodies, Monoclonal, Humanized / Chemoradiotherapy Limits: Aged / Female / Humans / Male / Middle aged Language: En Journal: Cancer Sci Year: 2018 Document type: Article Affiliation country: Japón Country of publication: Reino Unido
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Esophageal Neoplasms / Antineoplastic Combined Chemotherapy Protocols / Antibodies, Monoclonal, Humanized / Chemoradiotherapy Limits: Aged / Female / Humans / Male / Middle aged Language: En Journal: Cancer Sci Year: 2018 Document type: Article Affiliation country: Japón Country of publication: Reino Unido